The current institutional shareholding score of Lixte Biotechnology Holdings Inc is 3.00, ranking 193 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 8.14%, representing a quarter-over-quarter decrease of 4.01%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.80% of shares outstanding, with 29.20% increase in holdings.